Gender Comparison of some Apolipoprotein and Lipid Profiles in Apparently Healthy Adult Male and Female Subjects at Nnamdi Azikiwe University Teaching Hospital, Nnewi, South-Eastern Nigeria
International Journal of Pathogen Research, Volume 12, Issue 3,
Apolipoproteins are a group of proteins that are found on the surface of lipoprotein particles and are involved in lipid metabolism. Lipoproteins are complexes of lipids and proteins that transport lipids in the bloodstream, transport triglycerides to peripheral tissues, and reverse transport of cholesterol from peripheral tissues to the liver for excretion. They are important biomarkers of lipid metabolism and are known to be associated with an increased risk of CVD. This study aims to assess the effect of gender on some of the apolipoproteins and lipid profiles studied at Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi. A total of 51 adult female and 49 adult male subjects were randomly recruited at the Voluntary and counseling center NAUTH. The apolipoproteins such as Apo A-1, Apo A-2, Apo B, Apo C-2, Apo C-3, and Apo E, and the lipoproteins such as Total cholesterol (Chol), Low-Density Lipids (LDL), High-Density Lipids (HDL), and Triglycerides (TG) were analyzed using routine laboratory analyses. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 21, independent Students’-test, and one-way analysis of variance (ANOVA) were used to compare means. The Apo A-1, Apo A-2, Apo B, Chol, HDL, and TG levels were significantly elevated in the male subjects compared to the female subjects with p<0.05. Conclusively, the male subjects studied were more prone to cardiovascular conditions.
- lipid profiles
- cardiovascular disease
How to Cite
Omilabu TO. The prevalence of risk factors for the development of cardiovascular diseases in Nigeria. In Youth Science Week. 2021;2021:379-80.
Manrique-Acevedo C, Chinnakotla B, Padilla J, Martinez-Lemus LA, Gozal D. Obesity and cardiovascular disease in women. Int J Obes (Lond). 2020;44(6): 1210-26.
Kittnar O. Selected sex related differences in pathophysiology of cardiovascular system. Physiol Res. 2020;69(1):21-31.
Silva ITD, Almeida-Pititto BD, Ferreira SRG. Reassessing lipid metabolism and its potentialities in the prediction of cardiovascular risk. Arch Endocrinol Metab. 2015;59(2):171-80.
Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol. 2022;19(3):168-79.
Cho KH. The current status of research on high-density lipoproteins (HDL): A paradigm shift from HDL quantity to HDL quality and HDL functionality. Int J Mol Sci. 2022;23(7):3967.
Yu Q, Zhang Y, Xu CB. Apolipoprotein B, the villain in the drama? Eur J Pharmacol. 2015;748:166-9.
Huang JK, Lee HC. Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL). Int J Mol Sci. 2022; 23(8):4300.
Feingold KR. Introduction to lipids and lipoproteins. In: Endotext [internet]; 2021, Jan 19 Feingold KR, Anawalt B, Blackman MR, et al., editors. South Dartmouth. com, Inc. Text; 2000.
Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Effects of gender, age and menopausal status on serum apolipoprotein concentrations. Clin Endocrinol (Oxf). 2016;85(5):733- 40.
Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2015;15(1):130.
Kim Y, Lee Y, Lee SR, Choi SH, Park YJ. Gender differences in lipid metabolism in patients with Alzheimer’s disease: a retrospective study. Sci Rep. 2020;10(1):1.
Tietz NW. Clinical guild to laboratory tests 1983. Edited, Phipladelphia. Saunders, Co. p. 483.
Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of Total serum cholesterol. Clin Chem. 1974; 20(4):470-5.
Buccolo G, David H. Quantitative determination of serum triglycerides by the use of Enzymes. J Chem. 1973;19476-482.
Assmann G, Jabs HU, Nolte W, Schriewer H. LDL- cholesterol determination in blood serum following precipitation of LDL with polyvinyl sulphate. Clin Chim Acta. 1984; 140:77-83.
Kaplan A, Szabo L, Opheim K. Clinical chemistry interpretation and techniques. 3rd ed.Published by Lea and Febiger at 600 Washington Square Philadelphia. USA; 1983. p. 307-16.
Nakhjavani M, Larry M, Nargesi AA, Mostafavi E, Mirmiranpour H, et al. Gender-related differences in HDL structure with the progression of microalbuminuria in patients with Type 2 diabetes. J Diabetes Metab Disord Control. 2015;2(3):00043.
Ezeugwunne IP, Ejiogu IC, Oguaka VN, Ibemere OD, Elosiuba NV, Blessing K, et al. Ahaneku, Charles Chinedum Onyenekwe, Gladys.I. Ahaneku. Gender Comparison of Apolipoprotein and Lipid Profiles in Hiv Seropositives In Nauth. IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB). ISSN: 2455-264X;7(5):55-61; 2021.
Srivastava RK, Srivastava N. High density lipoprotein, apolipoprotein A1 and coronary artery disease. Biochem Mol Cell. 2000; 209:131-44.
Silver DL, Wang N, Xiao X, Tall AR. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem. 2001; 276(27):25287-93.
Rader DJ. Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol. 2003;92(4A): 42J-9J.
Arai Y, Hirose N. Aging and HDL metabolism in elderly people more than 100 years old. J Atheroscler Thromb. 2004;11(5):246-52.
Kuyl JM, Mendelsohn D. Observed relationship between ratios HDL-cholesterol/total cholesterol and apolipoprotein A1/apolipoprotein B. Clin Biochem. 1992;25(5):313-6.
Ogbodo EC, Ezeugwunne IP, Bakare EE, Analike RA, Njoku-Oji NN, Ugwu MC et al. Evaluation of Apo-lipoproteins and troponin levels in postmenopausal women in Nnewi Metropolis, Anambra State, Nigeria. Acta Med Sci. 2018 E-ISSN: 2454-3594;05:.
Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation. 1996; 94(3):273-8.
Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001; 358(9298):2026-33.
van Lennep JE, Westerveld HT, van Lennep HW, Zwinderman AH, Erkelens DW, van der Wall EE. Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol. 2000;20(11):2408-13.
Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S et al. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation. 2000; 101(5):477-84.
Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL et al. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res. 1988;29(11): 1461-73.
Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non–high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112(22):3375-83.
Jackson RL, Baker HN, Gilliam EB, Gotto AM. Primary structure of Very Low Density apolipoprotein C-11 of human plasma. Proc Natl Acad Sci USA. 1977;74(5):1942-5.
Singh PP, Singh M, Mastana SS. Genetic variation of apolipoproteins in North Indians. Hum Biol. 2002;74(5):673-82.
Larkin L, Khachigian LM, Jessup W. Regulation of apolipoprotein E production in macrophages (review) [review]. Int J Mol Med. 2000;6(3):253-8.
Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis. J Neurol Sci. 2006;245(1-2):35-9.
Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H, Jeong SM. High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population. BMC Neurol. 2019;19(1):147.
Gebreegziabiher G, Belachew T, Mehari K, Tamiru D. Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. Plos One. 2021;16(2): e0243103.
Chinechelum AR, Ekenedilichukwu OJ, Chukwuemeka MS, Adamma AR, Chukwuemeka OE. Evaluation of dyslipidemia prevalence among undergraduate university students. J J Clin Res Rep. 2022;12(1).
Almaqati T, Gazwani AM, Taha M, Almusabi S, Elnagi EA, Maawadh RM et al. The impact of age, gender and fasting blood glucose on serum lipid profile at tertiary care hospital: a retrospective study. Acta Biomed. 2022;93(6):e2022341.
Zhang P, Su Q, Ye X, Guan P, Chen C, Hang Y et al. Trends in LDL-C and non-HDL-C levels with age. Aging Dis. 2020;11(5):1046-57.
Kabiri N, Asgary S, Madani H, Mahzouni P. Effects of Amaranthus caudatus extract and lovastatin an atherosclerosis in hypercholesterolemic rabbits. Journal of Medicinal plants Respiration. 2010;4(5): 355 -381.
Joseph E. Ahaneku, Cosmas M. Nwosu, Gladys I. Ahaneku, Adeola Farotimia. Lipid and Lipoprotein cardiovascular Risk factor Responses to Episodic Academic Stress. Journal of Health Sciences. 2001;47(3): 323-326.
Abstract View: 18 times
PDF Download: 11 times